Clinical Trial

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Study acronym: PULSAR
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2022-07-15; most recent amendment 2026-01-28.
Status change: Recruiting → Active, Not Recruiting 2026-01-28
Status change: Active, Not Recruiting → Recruiting 2025-06-13
Status change: Recruiting → Active, Not Recruiting 2025-04-07
Status change: Not Yet Recruiting → Recruiting 2023-04-14
Trial Details
NCT Number NCT05462145
Lead Sponsor Kardium Inc.
Conditions Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
Enrollment 549 participants
Start Date 2023-03-09
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-01-30